State Street SPDR S&P Pharmaceuticals ETF
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
基本資料
種類: ETF
費用比率%: 0.35
資產淨值: 55.46
成立日期: 19/06/2006
 
分析
市值分佈:
40.84%
大市值 		43.53%
中市值 		14.07%
小市值
持股比例加總可能不達100%，原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間： 07/03/2026 05:58) 總持有投資項目: 59  
0%
 
100%
     10大 (23.32%)
代號 名稱 佔比% ▼ 持有日期
HROWHarrow2.0027/02/2026
LGNDLigand Pharmaceuticals2.0027/02/2026
PFEPfizer1.9927/02/2026
LLYEli Lilly & Co1.9627/02/2026
EYPTEyePoint Inc.1.9527/02/2026
MAZEMaze Therapeutics Inc1.9027/02/2026
OGNOrganon & Co1.8827/02/2026
ARVNArvinas1.8627/02/2026
DICE--1.8131/07/2023
PRGOPerrigo Company PLC1.8127/02/2026
RAPPRapport Therapeutics Inc.1.8027/02/2026
LQDALiquidia Corp1.7627/02/2026
TERNTerns Pharmaceuticals1.7527/02/2026
TARSTarsus Pharmaceuticals1.7227/02/2026
INDVIndivior Pharmaceuticals Inc.1.7127/02/2026
ANIPANI Pharmaceuticals1.6727/02/2026
XERSXeris Biopharma Holdings1.6327/02/2026
ESPREsperion Therapeutics1.6227/02/2026
PCRXPacira BioSciences1.6127/02/2026
CRNXCrinetics Pharmaceuticals1.5927/02/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.